CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-05). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2282 · Search date 2026-08-05 · Methodology v0.6

Tattooing,
does it really help with Higher incidence of skin cancer?

30-Second Summary
C
Evidence Grade C · 56 · Safety caution
A skin-cancer signal was observed, but events were sparse and sun-exposure confounding remained
Tattooing can cause infection, allergic reactions, and scarring, so sterile practice and appropriate aftercare matter. New or changing lesions, including changes obscured by ink, warrant clinical assessment.
What the
research shows
The grade is C. A cohort analysis in a random Danish twin sample linked tattooing with skin cancer, but only 16 cancers occurred. In a separate cancer-case/cotwin sample, an individual-level analysis was positive while the actual matched comparison of 14 informative twin pairs was null. Sun exposure and skin phototype were not adjusted, preventing a causal conclusion.
What the
ads claim
The paper also examined lymphoma, but that is a different endpoint and was not evidence for this skin-cancer verdict. Mechanistic concerns about ink alone cannot establish cancer incidence.
*

Useful facts when choosing a product

  • The random-sample cohort and cancer-case/cotwin analyses used different samples.
  • Only 16 skin cancers occurred in the cohort, eight among tattooed participants.
  • The matched analysis had only 14 pairs informative for both tattoo and skin cancer.
  • Sun exposure and skin phototype were not adjusted.
Gap Measurement · Verdict 2282 · C 56
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Clemmensen and colleagues linked a 2021 questionnaire to the Danish Cancer Registry. In the random twin cohort of 2,367 respondents, 16 skin cancers occurred, eight among tattooed participants, and the cohort HR was 3.91, 95% CI 1.42-10.8. In a separate 316-person cancer-case/cotwin sample, the individual-level analysis included 119 cases and 104 controls and gave HR 1.62, 1.08-2.41; the actual matched comparison of 14 pairs discordant for both tattoo and skin cancer gave HR 1.33, 0.46-3.84. These samples and analyses are distinct. Outdoor ultraviolet exposure, sunburn, and skin phototype were not measured or adjusted. The paper confirms open-access funding from the University of Southern Denmark and declares no competing interests. Nordic Cancer Union research funding was not confirmed, and tattoo-industry funding was not separately stated. Exposure-group-specific absolute skin-cancer incidence was not provided.

02

Why this is classified as C (56)

Registry-confirmed cancer and time-varying exposure are strengths. One research group, sparse events, modest response, unadjusted ultraviolet and phenotype confounding, and an imprecise matched analysis give C with 56 points.

Counterpoint. The positive associations deserve attention but do not establish that tattooing causes skin cancer. Greater ultraviolet exposure and skin-phenotype differences could explain part of the signal.

Rejudgment record. Cross-check applied — Separate accounting of cohort, individual, and matched cotwin estimates, events, and ultraviolet confounding

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Higher skin-cancer incidence in the random twin sampleCAcross 16 events, HR was 3.91, 95% CI 1.42-10.8.
Higher skin-cancer incidence in the matched cotwin analysisDAcross 14 informative pairs, HR was 1.33, 95% CI 0.46-3.84.
Higher skin-cancer incidence with large tattoosCIn the individual-level analysis, HR was 2.37 for large and 1.37 for small tattoos; this was not the matched analysis.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Registry-linked cohort and case-cotwin comparison14Open-access funding from the University of Southern Denmark; Nordic Cancer Union research funding was not confirmed, and tattoo-industry funding was not separately statedIncident skin cancer, with basal cell carcinoma handled separately in some analysesCohort analysis HR 3.91 (1.42-10.8); individual-level analysis in the separate sample HR 1.62 (1.08-2.41); 14-pair matched analysis HR 1.33 (0.46-3.84)Objective registry endpoint, but sparse events and pairs with unadjusted ultraviolet confounding
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-05).

Clemmensen SB, Mengel-From J, Kaprio J, Frederiksen H, Hjelmborg JvB. BMC Public Health. 2025;25:170. PMID: 39819495. DOI: 10.1186/s12889-025-21413-3.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-05 · Corrections: none

Cite this verdict

Tattooing x skin cancer Evidence Grade C card
[Chamgap] Tattooing x skin cancer — Evidence Grade C·56. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/tattoo-skin-cancer/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.